Skip to content
AwardedMLTGoods€2,371,742

CT2095/2024 - Tender for the supply of Ustekinumab 45mg Solution for Injection, Ustekinumab 90mg Solution for Injection, and Ustekinumab 130mg Concentrate for Solution for Infusion

Published
Published 14 April 2025
Deadline
Closed 3 September 2024

Overview

CT2095/2024 - Tender for the supply of Ustekinumab 45mg Solution for Injection, Ustekinumab 90mg Solution for Injection, and Ustekinumab 130mg Concentrate for Solution for Infusion

Key details

Country
MLT
Status
Awarded
Category
Goods
Estimated value
€2,371,742
Procedure
Open
Published
14 April 2025
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€2,371,742
Award date
10 April 2025
Winner
  • PHARMA.MT LTD

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    14 April 2025

  2. Contract Notice

    9 July 2024

  3. Contract Notice

    26 June 2024

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: CT2095/2024 - Tender for the supply of Ustekinumab 45mg Solution for Injection, Ustekinumab 90mg Solution for Injection, and Ustekinumab 130mg Concentrate for Solution for Infusion — won by PHARMA.MT LTD — Skim